These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 5421804)

  • 1. [Clinical action in vascular pathology of the limbs, of an original association of raubasine and 711 SE].
    Bouret G; Coget JM; Merlen JF; Warembourg H
    Lille Med; 1970 Mar; 15(3 Suppl 2):440-3. PubMed ID: 5421804
    [No Abstract]   [Full Text] [Related]  

  • 2. [Raubasine in arterial pathology of the extremities].
    Perrin M
    Lyon Med; 1965 May; 213(21):1585-90. PubMed ID: 5828799
    [No Abstract]   [Full Text] [Related]  

  • 3. [Study of the association of raubasine and dihydroergocristine in the aged patient with vascular disease].
    Sauter R
    Lille Med; 1971; 17():Suppl 3:551-8. PubMed ID: 5005074
    [No Abstract]   [Full Text] [Related]  

  • 4. [Our experience in the treatment of peripheral vascular diseases with raubasine].
    Vercellio G; Costantini S; Giulini S
    Minerva Cardioangiol; 1972 Apr; 20(4):217-30. PubMed ID: 5023726
    [No Abstract]   [Full Text] [Related]  

  • 5. [The association of raubasine and ergot derivatives in therapy of peripheral vascular diseases].
    Sforza M; Perelli-Ercolini M
    Minerva Cardioangiol; 1967 Oct; 15(10):655-8. PubMed ID: 5611109
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical considerations on the use of a drug with vasodilating hemokinetic action in cerebral and peripheral vascular diseases].
    Florio F; Ruffolo S; Piro E
    Minerva Cardioangiol; 1976 Feb; 24(2):161-70. PubMed ID: 1256656
    [No Abstract]   [Full Text] [Related]  

  • 7. [A new method of treating arteriopathy of the extremities with a pharmacologically original substance].
    Royer R; Debry G; Duc M
    Therapeutique; 1969 Mar; 45(3):308-12. PubMed ID: 5386064
    [No Abstract]   [Full Text] [Related]  

  • 8. [Action of MD 1035 in peripheral vascular manifestations].
    Barraine R; Efthymiou TP; Marcantoni JP
    Presse Med (1893); 1970 Dec; 78(53):2389-90. PubMed ID: 5489156
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical evaluation of Cinnarizine in patients with peripheral vascular diseases].
    Simões Neto E
    Hospital (Rio J); 1971 Jan; 79(1):189-98. PubMed ID: 5316651
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical trial of cinnarizine in some vascular diseases].
    Triandaf I; Cosma M; Triandaf N
    Rev Med Chir Soc Med Nat Iasi; 1976; 80(1):19-22. PubMed ID: 135327
    [No Abstract]   [Full Text] [Related]  

  • 11. [Defluine (an association of raubasine and ergot derivatives) in the treatment of senile cerebral vascular diseases of a sclerotic nature].
    Turri C
    Minerva Med; 1970 Aug; 61(65):3466-76. PubMed ID: 5451093
    [No Abstract]   [Full Text] [Related]  

  • 12. [Controlled clinical study on the activity and tolerance of Trivastan].
    Nicrosini F; Pasotti C
    Minerva Med; 1976 May; 67(26):1745-50. PubMed ID: 778674
    [No Abstract]   [Full Text] [Related]  

  • 13. [Therapeutic use of piribedil in vascular diseases of the eye].
    Solé P; Rigal D; Bacin F
    Minerva Med; 1976 May; 67(26):1689-95. PubMed ID: 934521
    [No Abstract]   [Full Text] [Related]  

  • 14. [Study on the effect of Sibelium (flunarizine) in blood circulation disorders. A multicentric double-blind study].
    Nelson M; Dewitz G; Dom J; Hörig C
    Med Welt; 1978 Jul; 29(29-30):1175-81. PubMed ID: 672587
    [No Abstract]   [Full Text] [Related]  

  • 15. [Raubasine-peridural infiltration combination in therapy of obstructive arteriopathies of the lower extremities].
    Giubbolini G; Setacci C; Romei R; Federici L
    Minerva Cardioangiol; 1980 Mar; 28(3):177-82. PubMed ID: 7383367
    [No Abstract]   [Full Text] [Related]  

  • 16. [Report on the use of piribedil in vascular and hemorrhagic disease of the posterior pole of the eyeball].
    De Molfetta V; Lauri G
    Minerva Med; 1976 May; 67(26):1696-7. PubMed ID: 934522
    [No Abstract]   [Full Text] [Related]  

  • 17. [Report on the clinical trial with lamuran (II)].
    Steinorth G
    Med Welt; 1967 Sep; 36():2110-5. PubMed ID: 5614247
    [No Abstract]   [Full Text] [Related]  

  • 18. [Changes in blood serum protein fractions in obliterating vascular diseases of the extremities following nivaline-electrophoresis therapy].
    Todorov N
    Vopr Kurortol Fizioter Lech Fiz Kult; 1970; 35(6):512-6. PubMed ID: 5515367
    [No Abstract]   [Full Text] [Related]  

  • 19. Pathophysiology of postischemic hypoxia and cerebral protection: implications of the almitrine and raubasine combination.
    Chan P
    Eur Neurol; 1995; 35 Suppl 1():23-7. PubMed ID: 8529726
    [No Abstract]   [Full Text] [Related]  

  • 20. [Antinoradrenergic activity of raubasine on isolated thoracic aorta and vas deferens of rat (author's transl)].
    Roquebert J; Gomond P; Demichel P
    J Pharmacol; 1981; 12(4):393-403. PubMed ID: 6119400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.